Zolmitriptan NDC 46708-181

NDC codes

FDA NDC Directory

Product NDC (as listed)46708-181Labeler and product segments. Claims need a package NDC.

Product NDC at billing width46708-0181Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
46708-181-06	46708018106	6 BLISTER PACK in 1 CARTON (46708-181-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACKMarketed from Dec 1, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zolmitriptan
Generic name (nonproprietary): zolmitriptan
Active ingredients: Zolmitriptan — 2.5 mg/1
Dosage form: Tablet, Orally disintegrating
Route: Oral
Labeler: Alembic Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205074
Marketing start: Dec 1, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 46708-181_052016e5-acea-4d2a-8d76-cef36eb99262SPL ID 052016e5-acea-4d2a-8d76-cef36eb99262SPL set ID b8d657ac-dbda-4455-8bb5-3896951c3b67RxCUI 284201, 351134UNII 2FS66TH3YW
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N446708018106 followed by a unit qualifier and the quantity

Package 46708-0181-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 22, 2024.

Indications (excerpt from the label)

Zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. Zolmitriptan is not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan have not been established for cluster headache. Zolmitriptan is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults (1) Limitation…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205074

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205074
Product	Strength	Form · route	Labeler	Product NDC
Zolmitriptan	Zolmitriptan 5 mg/1	Tablet, Orally disintegratingOral	Alembic Pharmaceuticals Limited	46708-182
Zolmitriptan	Zolmitriptan 2.5 mg/1	Tablet, Orally disintegratingOral	Alembic Pharmaceuticals Inc.	62332-181
Zolmitriptan	Zolmitriptan 5 mg/1	Tablet, Orally disintegratingOral	Alembic Pharmaceuticals Inc.	62332-182